Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy

Stroke Vasc Neurol. 2023 Aug;8(4):263-265. doi: 10.1136/svn-2023-002321. Epub 2023 Feb 16.
No abstract available

Keywords: COVID-19.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / adverse effects
  • COVID-19*
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects

Substances

  • Fibrinolytic Agents
  • Anticoagulants
  • Platelet Aggregation Inhibitors